Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

The design and baseline data of the PRECISION study, which evaluates the effect of the dual endothelin receptor antagonist aprocitentan on blood pressure (BP) in patients with resistant hypertension (RHT) are presented. The study is a blinded, randomized, parallel‐group Phase 3 study and its three‐p...

Descripción completa

Detalles Bibliográficos
Autores principales: Danaietash, Parisa, Verweij, Pierre, Wang, Ji‐Guang, Dresser, George, Kantola, Ilkka, Lawrence, Mary Katherine, Narkiewicz, Krzysztof, Schlaich, Markus, Bellet, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278594/
https://www.ncbi.nlm.nih.gov/pubmed/35686330
http://dx.doi.org/10.1111/jch.14517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278594/
https://www.ncbi.nlm.nih.gov/pubmed/35686330
http://dx.doi.org/10.1111/jch.14517

Ejemplares similares